Market Analysis and Insights:
The global Pharmaceutical Amino Acids market was valued at US$ 1,326.13 million in 2021 and will reach US$ 1,569.19 million by the end of 2028, growing at a CAGR of 2.5% during 2022-2028.
In the industry, the key players in the global Pharmaceutical Amino Acids market are like Ajinomoto, Evonik, Kyowa Hakko, AMINO, Meihua Holding Group, Tianjin Tianyao, Jingjing, Wuxi Jinghai, Jiahe Biotech, Hubei Bafeng, Grand Hoyo, Yichang Sanxia Proudin and Shine Star, etc. Ajinomoto shipments most in 2021 and recent years, while Evonik and Kyowa Hakko ranked 2 and 3.The gap of market share is keep on enlarged due to different strategy. The market concentration ratio in the past three years. The top five manufacturers held 67.44% of the market, in terms of Pharmaceutical Amino Acids revenue in 2021.
Asia has the largest global export quantity and manufacturers in Pharmaceutical Amino Acids market, global leading companies all have production bases in China.
Demand is growing worldwide in the market for amino acids for pharmaceuticals, and steady growth is forecast to continue. The demand for high-quality amino acids centering on the biopharmaceuticals business in particular is growing. Also, since development is proceeding on antibody drugs and biosimilars (follow-on biologics), strong growth is expected to continue in the culture media market for biopharmaceuticals. However, we must keep a close watch on factors such as distribution delays and the skyrocketing costs of raw materials and fuel stemming from the Ukraine situation.
On the basis of amino acids type, the Pharmaceutical Amino Acids market has been segmented into Glycine, L-Threonine, L-Alanine, L-Leucine, L-Cysteine, L-Arginine, L-Valine, L-Isoleucine and Others. Glycine is the largest type, Glycine accounts for about 31.68% of the total sales in 2021, with a sales volume of 16,650 metric tons. The L-Alanine and L-Isoleucine segment of Pharmaceutical Amino Acids is projected to register the highest CAGR during the forecast period.
Active Pharmaceuticals Ingredients (APIs) is estimated to be the largest application of Pharmaceutical Amino Acids. Cell Culture Media Ingredients are expected to show the fastest growth rates in the Pharmaceutical Amino Acids market in the coming years.
Affected by the COVID-19, the operating rate of small manufacturer has declined, and the market share of large manufacturer has increased rapidly. It is expected that major manufacturer will continue to expand production capacity in the next five years.
The market growth rate (by volume) is expected to exceed 6.99% in 2022.
On the basis of region, the Pharmaceutical Amino Acids market has been segmented into Asia, Europe, USMCA, Middle East, CIS, Central & South America, Africa, Oceania. USMCA is projected to be the largest market during the forecast period. The demand for Pharmaceutical Amino Acids is high in developing economies such as China and India. High growth and innovation, along with industry consolidations, are expected to drive the market in the region.
In terms of production side, this report researches the Pharmaceutical Amino Acids capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2017 to 2022, and forecast to 2028.
The production capacity in this report is mainly based on the nameplate capacity, and the manufacturer's capacity data includes the part of the joint venture.
It should be pointed out that the revenue market size described in this report refers to the output value calculated according to the market price of Pharmaceutical Amino Acids. Most Pharmaceutical Amino Acids production enterprises have downstream derivatives manufacturing business, and the Pharmaceutical Amino Acids traded between enterprises are usually quoted based on the market price, plus processing fees.
In this report, MT refers to Metric Tones.
In terms of sales side, this report focuses on the sales of Pharmaceutical Amino Acids by regions (countries), company, by Progress and by Application. from 2017 to 2022 and forecast to 2028.
The global Pharmaceutical Amino Acids market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Progress segment of the global Pharmaceutical Amino Acids market. These figures have been provided in terms of both revenue and volume for the period 2017-2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
By Company
- Ajinomoto
- Evonik
- Kyowa Hakko
- AMINO
- Meihua Holding Group
- Tianjin Tianyao
- Jingjing
- Wuxi Jinghai
- Jiahe Biotech
- Hubei Bafeng
- Grand Hoyo
- Yichang Sanxia Proudin
- Shine Star
Segment by Type
- Glycine
- L-Threonine
- L-Alanine
- L-Leucine
- L-Cysteine
- L-Arginine
- L-Valine
- L-Isoleucine
- Others
Segment by Application
- Active Pharmaceuticals Ingredients (APIs)
- Pharmaceutical Intermediates
- Cell Culture Media Ingredients
- Pharmaceutical Excipients
- Medical Food
- Others
Sales by Region
- Asia Pacific
- Europe
- USMCA
- Middle East and Africa
- CIS
- Central & South America
- China
- Japan
- South Korea
- India
- Taiwan China
- Indonesia
- Thailand
- Germany
- France
- Italy
- United Kingdom
- Netherlands
- Spain
- Switzerland
- United States
- Mexico
- Canada
- Saudi Arabia
- Iran
- Brazil
- Argentina
TABLE OF CONTENTS
1 PHARMACEUTICAL AMINO ACIDS MARKET OVERVIEW
- 1.1 Pharmaceutical Amino Acids Product Overview
- 1.2 Pharmaceutical Amino Acids Market Segment by Type
- 1.2.1 Glycine
- 1.2.2 L-Threonine
- 1.2.3 L-Alanine
- 1.2.4 L-Leucine
- 1.2.5 L-Cysteine
- 1.2.6 L-Arginine
- 1.2.7 L-Valine
- 1.2.8 L-Isoleucine
- 1.2.9 Others
- 1.3 Global Pharmaceutical Amino Acids Market Size by Type
- 1.3.1 Global Pharmaceutical Amino Acids Market Size Overview by Type (2017-2028)
- 1.3.2 Global Pharmaceutical Amino Acids Historic Market Size Review by Type (2017-2022)
- 1.3.3 Global Pharmaceutical Amino Acids Forecasted Market Size by Type (2023-2028)
- 1.4 Key Regions Market Size Segment by Type
- 1.4.1 USMCA Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.2 Europe Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.3 Asia Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.4 Middle East Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.6 CIS Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.7 Africa Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
- 1.4.8 Oceania Pharmaceutical Amino Acids Sales Breakdown by Type (2017-2022)
2 PHARMACEUTICAL AMINO ACIDS MARKET COMPETITION BY COMPANY
- 2.1 Global Top Players by Pharmaceutical Amino Acids Sales (2017-2022)
- 2.2 Global Top Players by Pharmaceutical Amino Acids Revenue (2017-2022)
- 2.3 Global Top Players by Pharmaceutical Amino Acids Price (2017-2022)
- 2.4 Global Top Manufacturers Pharmaceutical Amino Acids Manufacturing Base
- 2.5 Pharmaceutical Amino Acids Market Competitive Situation and Trends
- 2.5.1 Pharmaceutical Amino Acids Market Concentration Rate (2017-2022)
- 2.5.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Amino Acids Sales and Revenue in 2021
- 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Amino Acids as of 2021)
3 PHARMACEUTICAL AMINO ACIDS STATUS AND OUTLOOK BY REGION
- 3.1 Global Pharmaceutical Amino Acids Market Size and CAGR by Region: 2017 VS 2021 VS 2028
- 3.2 Global Pharmaceutical Amino Acids Historic Market Size by Region
- 3.2.1 Global Pharmaceutical Amino Acids Sales in Volume by Region (2017-2022)
- 3.2.2 Global Pharmaceutical Amino Acids Sales in Value by Region (2017-2022)
- 3.2.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price and Gross Margin (2017-2022)
- 3.3 Global Pharmaceutical Amino Acids Forecasted Market Size by Region
- 3.3.1 Global Pharmaceutical Amino Acids Sales in Volume by Region (2023-2028)
- 3.3.2 Global Pharmaceutical Amino Acids Sales in Value by Region (2023-2028)
- 3.3.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price and Gross Margin (2023-2028)
4 PHARMACEUTICAL AMINO ACIDS BY APPLICATION
- 4.1 Pharmaceutical Amino Acids Market Segment by Application
- 4.1.1 Active Pharmaceuticals Ingredients (APIs)
- 4.1.2 Pharmaceutical Intermediates
- 4.1.3 Cell Culture Media Ingredients
- 4.1.4 Pharmaceutical Excipients
- 4.1.5 Medical Food
- 4.1.6 Others
- 4.2 Global Pharmaceutical Amino Acids Market Size by Application
- 4.2.1 Global Pharmaceutical Amino Acids Market Size Overview by Application (2017-2028)
- 4.2.2 Global Pharmaceutical Amino Acids Historic Market Size Review by Application (2017-2022)
- 4.2.3 Global Pharmaceutical Amino Acids Forecasted Market Size by Application (2023-2028)
- 4.3 Key Regions Market Size Segment by Application
- 4.3.1 USMCA Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.2 Europe Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.3 Asia Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.4 Middle East Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.6 CIS Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.7 Africa Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
- 4.3.8 Oceania Pharmaceutical Amino Acids Sales Breakdown by Application (2017-2022)
5 USMCA PHARMACEUTICAL AMINO ACIDS BY REGION
- 5.1 USMCA Pharmaceutical Amino Acids Historic Market Size by Region
- 5.1.1 USMCA Pharmaceutical Amino Acids Sales in Volume by Region (2017-2022)
- 5.1.2 USMCA Pharmaceutical Amino Acids Sales in Value by Region (2017-2022)
- 5.2 USMCA Pharmaceutical Amino Acids Forecasted Market Size by Region
- 5.2.1 USMCA Pharmaceutical Amino Acids Sales in Volume by Region (2023-2028)
- 5.2.2 USMCA Pharmaceutical Amino Acids Sales in Value by Region (2023-2028)
6 ASIA PHARMACEUTICAL AMINO ACIDS BY REGION
- 6.1 Asia Pharmaceutical Amino Acids Historic Market Size by Region
- 6.1.1 Asia Pharmaceutical Amino Acids Sales in Volume by Region (2017-2022)
- 6.1.2 Asia Pharmaceutical Amino Acids Sales in Value by Region (2017-2022)
- 6.2 Asia Pharmaceutical Amino Acids Forecasted Market Size by Region
- 6.2.1 Asia Pharmaceutical Amino Acids Sales in Volume by Region (2023-2028)
- 6.2.2 Asia Pharmaceutical Amino Acids Sales in Value by Region (2023-2028)
7 EUROPE PHARMACEUTICAL AMINO ACIDS BY COUNTRY
- 7.1 Europe Pharmaceutical Amino Acids Historic Market Size by Country
- 7.1.1 Europe Pharmaceutical Amino Acids Sales in Volume by Country (2017-2022)
- 7.1.2 Europe Pharmaceutical Amino Acids Sales in Value by Country (2017-2022)
- 7.2 Europe Pharmaceutical Amino Acids Forecasted Market Size by Country
- 7.2.1 Europe Pharmaceutical Amino Acids Sales in Volume by Country (2023-2028)
- 7.2.2 Europe Pharmaceutical Amino Acids Sales in Value by Country (2023-2028)
8 MIDDLE EAST PHARMACEUTICAL AMINO ACIDS BY REGION
- 8.1 Middle East Pharmaceutical Amino Acids Historic Market Size by Region
- 8.1.1 Middle East Pharmaceutical Amino Acids Sales in Volume by Region (2017-2022)
- 8.1.2 Middle East Pharmaceutical Amino Acids Sales in Value by Region (2017-2022)
- 8.2 Middle East Pharmaceutical Amino Acids Forecasted Market Size by Region
- 8.2.1 Middle East Pharmaceutical Amino Acids Sales in Volume by Region (2023-2028)
- 8.2.2 Middle East Pharmaceutical Amino Acids Sales in Value by Region (2023-2028)
9 CENTRAL & SOUTH AMERICA PHARMACEUTICAL AMINO ACIDS BY REGION
- 9.1 Central & South America Pharmaceutical Amino Acids Historic Market Size by Region
- 9.1.1 Central & South America Pharmaceutical Amino Acids Sales in Volume by Region (2017-2022)
- 9.1.2 Central & South America Pharmaceutical Amino Acids Sales in Value by Region (2017-2022)
- 9.2 Central & South America Pharmaceutical Amino Acids Forecasted Market Size by Region
- 9.2.1 Central & South America Pharmaceutical Amino Acids Sales in Volume by Region (2023-2028)
- 9.2.2 Central & South America Pharmaceutical Amino Acids Sales in Value by Region (2023-2028)
10 COMPANY PROFILES AND KEY FIGURES IN PHARMACEUTICAL AMINO ACIDS BUSINESS
- 10.1 Ajinomoto (Japan)
- 10.1.1 Ajinomoto Corporation Information
- 10.1.2 Ajinomoto Introduction and Business Overview
- 10.1.3 Ajinomoto Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.1.4 Ajinomoto Pharmaceutical Amino Acids Products Offered
- 10.1.5 Ajinomoto Recent Development
- 10.2 Evonik (Germany)
- 10.2.1 Evonik Corporation Information
- 10.2.2 Evonik Introduction and Business Overview
- 10.2.3 Evonik Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.2.4 Evonik Pharmaceutical Amino Acids Products Offered
- 10.2.5 Evonik Recent Development
- 10.3 Kyowa Hakko (Japan)
- 10.3.1 Kyowa Hakko Corporation Information
- 10.3.2 Kyowa Hakko Introduction and Business Overview
- 10.3.3 Kyowa Hakko Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.3.4 Kyowa Hakko Pharmaceutical Amino Acids Products Offered
- 10.3.5 Kyowa Hakko Recent Development
- 10.4 AMINO (Germany)
- 10.4.1 AMINO Corporation Information
- 10.4.2 AMINO Introduction and Business Overview
- 10.4.3 AMINO Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.4.4 AMINO Pharmaceutical Amino Acids Products Offered
- 10.4.5 AMINO Recent Development
- 10.5 MeiHua Holdings Group (China)
- 10.5.1 MeiHua Holdings Group Corporation Information
- 10.5.2 MeiHua Holdings Group Introduction and Business Overview
- 10.5.3 MeiHua Holdings Group Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.5.4 MeiHua Holdings Group Pharmaceutical Amino Acids Products Offered
- 10.5.5 MeiHua Holdings Group Recent Development
- 10.6 Tianjin Tianyao (China)
- 10.6.1 Tianjin Tianyao Corporation Information
- 10.6.2 Tianjin Tianyao Introduction and Business Overview
- 10.6.3 Tianjin Tianyao Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.6.4 Tianjin Tianyao Pharmaceutical Amino Acids Products Offered
- 10.7 Jingjing (China)
- 10.7.1 Jingjing Corporation Information
- 10.7.2 Jingjing Introduction and Business Overview
- 10.7.3 Jingjing Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.7.4 Jingjing Pharmaceutical Amino Acids Products Offered
- 10.8 Wuxi Jinghai (China)
- 10.8.1 Wuxi Jinghai Corporation Information
- 10.8.2 Wuxi Jinghai Introduction and Business Overview
- 10.8.3 Wuxi Jinghai Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.8.4 Wuxi Jinghai Pharmaceutical Amino Acids Products Offered
- 10.9 Jiahe Biotech (China)
- 10.9.1 Jiahe Biotech Corporation Information
- 10.9.2 Jiahe Biotech Introduction and Business Overview
- 10.9.3 Jiahe Biotech Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.9.4 Jiahe Biotech Pharmaceutical Amino Acids Products Offered
- 10.10 Hubei Bafeng (China)
- 10.10.1 Hubei Bafeng Corporation Information
- 10.10.2 Hubei Bafeng Introduction and Business Overview
- 10.10.3 Hubei Bafeng Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.10.4 Hubei Bafeng Pharmaceutical Amino Acids Products Offered
- 10.10.5 Hubei Bafeng Recent Development
- 10.11 Grand Hoyo (China)
- 10.11.1 Grand Hoyo Corporation Information
- 10.11.2 Grand Hoyo Introduction and Business Overview
- 10.11.3 Grand Hoyo Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.11.4 Grand Hoyo Pharmaceutical Amino Acids Products Offered
- 10.11.5 Grand Hoyo Recent Development
- 10.12 Yichang Sanxia Proudin (China)
- 10.12.1 Yichang Sanxia Proudin Corporation Information
- 10.12.2 Yichang Sanxia Proudin Introduction and Business Overview
- 10.12.3 Yichang Sanxia Proudin Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.12.4 Yichang Sanxia Proudin Pharmaceutical Amino Acids Products Offered
- 10.12.5 Yichang Sanxia Proudin Recent Development
- 10.13 Shine Star (China)
- 10.13.1 Shine Star Corporation Information
- 10.13.2 Shine Star Introduction and Business Overview
- 10.13.3 Shine Star Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2017-2022)
- 10.13.4 Shine Star Pharmaceutical Amino Acids Products Offered
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 11.1 Pharmaceutical Amino Acids Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Key Raw Materials Price
- 11.1.3 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.3 Pharmaceutical Amino Acids Industrial Chain Analysis
- 11.4 Pharmaceutical Amino Acids Market Dynamics
- 11.4.1 Industry Trends
- 11.4.2 Market Drivers
- 11.4.3 Market Challenges
- 11.4.4 Market Restraints
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 12.1 Sales Channel
- 12.2 Pharmaceutical Amino Acids Distributors
- 12.3 Pharmaceutical Amino Acids Downstream Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown and Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
- 14.3 Disclaimer
- 14.4 Author List